Fair Allocation of Scarce CAR T-Cell Therapies for Relapsed/Refractory Multiple Myeloma.
JAMA
; 2023 Jul 31.
Article
en En
| MEDLINE
| ID: mdl-37523170
This Viewpoint discusses the unfairness of current CAR T-cell therapy allocation practices and offers alternative methods to more fairly allocate therapy.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
JAMA
Año:
2023
Tipo del documento:
Article